SCHEDULE 13G/A: BlackRock Discloses 7.7% Stake in Orthofix Medical Inc. via Latest SEC Filing
Beneficial Ownership Report
BlackRock, Inc. has filed an Amendment No. 5 to Schedule 13G, reporting a beneficial ownership of 7.7% in Orthofix Medical Inc. as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 2,989,175 shares of Orthofix Medical Inc. common stock.
- This ownership represents 7.7% of the total outstanding common stock of Orthofix Medical Inc.
- BlackRock holds sole voting power over 2,923,256 shares and sole dispositive power over 2,989,175 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of Orthofix Medical Inc.
- The filing is an Amendment No. 5 to a Schedule 13G, indicating an update to a previously reported stake.
- BlackRock Investment Management, LLC is specifically identified as one of the BlackRock subsidiaries that beneficially owns 5% or greater of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing beneficial ownership, which is neutral in sentiment. It provides factual information without expressing positive or negative outlooks on the issuer's performance or future prospects.
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
This filing indicates continued institutional investment by a major asset manager, BlackRock, in the healthcare and medical device sector, specifically Orthofix Medical Inc. It reflects BlackRock's ongoing portfolio management activities and its position as a significant passive investor in publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update | BlackRock, Inc. issued a new Power of Attorney, effective January 21, 2025, which revokes a previous one dated April 30, 2023. This new document authorizes specific individuals to execute and file various SEC and non-United States governmental or regulatory documents on behalf of BlackRock and its direct and indirect subsidiaries and affiliates. | 2025-01-21 | This update streamlines the process for BlackRock's authorized personnel to fulfill regulatory reporting requirements, ensuring continued compliance and efficiency in filing ownership and control-person reports. It does not indicate a change in corporate governance for Orthofix Medical Inc. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake, confirming BlackRock's continued investment in Orthofix Medical Inc.
- Company Management: Offers insight into the composition of the company's institutional shareholder base, although BlackRock explicitly states its holding is not for control purposes.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney revoked by BlackRock, Inc. |
| 2025-01-21 | Effective date of the new Power of Attorney issued by BlackRock, Inc. |
| 2025-03-31 | Date of event which requires filing of this statement, representing the reporting period end date for beneficial ownership. |
| 2025-04-17 | Date of filing of the Schedule 13G Amendment No. 5 with the SEC. |
Keywords
BlackRock, Orthofix Medical Inc., Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Devices, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.